Company Profile
Updated: 17-SEP-09Chiron Investment Corp.
Private Subsidiary, Headquarters Location
4560 Horton St., Emeryville, CA 94608-2916, United States
(800)524-4766, (510)655-8730, (510)655-9910 fax, http://www.chiron.com
Primary SIC: Investment Advice, Primary NAICS: Portfolio Management
Description: Finance: Investment Advice Services.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Telormedix Appoints Johanna Holldack as CEO.
Cancer Vaccine Week; 11/9/2009; 1403 words; ...Vaccines and Therapeutics at Chiron Corp. in Emeryville, USA and...Switzerland), Proquest Investments (Princeton-San Diego...Insurance, Finance, Investing, Investment, Venture Capital, Biopharmaceuticals...Company, Cancer Vaccines, Chiron Corporation, Clinical Research...
Genetronics Secures Two-Tranche Financing Of $15.7M.
BIOWORLD Today; 11/4/2009; 877 words; ...Editor Genetronics Biomedical Corp. intends to use the about...than cancer. For example, Chiron Corp, of Emeryville, Calif...Development and the strategic investment unit of Quintiles Transnational Corp. SCO Securities LLC acted...
Other News To Note.
BIOWORLD Today; 11/4/2009; 2210 words; ...against an appeal by Chiron Corp., of Emeryville...overturned. The appeal by Chiron was remitted back to...vaccines. DOR and Elan Corp. plc, of Dublin...in the state. If the investment is successful, the...anticipates making additional investments of $108 million over...
Ribozyme Expands Focus, Cuts Staff By 30 Employees.
BIOWORLD Today; 11/4/2009; 1421 words; ...an agreement with Geron Corp., of Menlo Park, Calif...said it is increasing its investment in its ribonucleic acid...Ribozyme is partnered with Chiron Corp., of Emeryville, Calif...collaborating with Elan Corp. plc, of Dublin, Ireland...
Chalk One Up For Shareholders: MedImmune Put Up For Sale.
BIOWORLD Today; 11/3/2009; 1614 words; ...closing Wednesday at $37.84. David Katz, president and chief investment officer of New York-based Matrix Asset Advisors, got the stock...Novartis AG's $5.4 billion purchase a year ago of the 56 percent of Chiron Corp. it didn
Recent News Articles
- Recommended Cash Offer by UBS Investment Bank* on Behalf of Chiron UK-1 Limited a Wholly-Owned Subsidiary of Chiron Corporation and (in the United States) by Chiron UK-1 Limited for PowderJect Pharmaceuticals plc; Offer Declared Unconditional in All Respects.
PR Newswire - July 08, 2003 - Recommended Cash Offer by UBS Investment Bank* on Behalf of Chiron UK-1 Limited a wholly-owned subsidiary of Chiron Corporation and (in the United States) by Chiron UK-1 Limited for PowderJect Pharmaceuticals plc.
PR Newswire - July 03, 2003 - Recommended Cash Offer by UBS Investment Bank* on Behalf of Chiron UK-1 Limited a wholly-owned subsidiary of Chiron Corporation and (in the United States) by Chiron UK-1 Limited for PowderJect Pharmaceuticals plc.
PR Newswire - June 24, 2003 - Recommended Cash Offer by UBS Investment Bank* on Behalf of Chiron UK-1 Limited a Wholly-Owned Subsidiary of Chiron Corporation and (in the United States) by Chiron UK-1 Limited for PowderJect Pharmaceuticals plc.
PR Newswire - June 10, 2003
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning
Related Company Profiles
- International Merchant Solutions L.L.C.
- Northern Trust Global Advisors Inc.
- Retirement System Investors Inc.